Kai Kappert
Impact in
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune cells in cancer
- Galectins and Cancer Biology
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Protein Tyrosine Phosphatases 17
- Peroxisome Proliferator-Activated Receptors 5
- Angiogenesis and VEGF in Cancer 5
- Immunology 14
- Galectins and Cancer Biology 8
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 7
- Co-authors
- Arne Östman (14 shared papers)Ulrich Kintscher (23 shared papers)R Tauber (11 shared papers)Eckart Fleck (14 shared papers)Stephan Rosenkranz (10 shared papers)Philipp Stawowy (18 shared papers)Thomas Unger (15 shared papers)Evren Caglayan (9 shared papers)
- Journals
- Biochemical and Biophysical Research Communications (5 papers)Hypertension (4 papers)Circulation Research (3 papers)PLoS ONE (3 papers)Circulation (2 papers)
- Partner nations
- GermanySwedenUnited States
In The Last Decade
Kai Kappert
97 papers receiving 3.2k citations
Kai Kappert's Hit Papers
Peers
Comparison fields: 5 of 124
- Immunology 737
- Infectious Diseases 560
- Immunology and Allergy 125
- Neurology 273
- Cancer Research 250
Countries citing papers authored by Kai Kappert
This map shows the geographic impact of Kai Kappert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Kappert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Kappert more than expected).
Fields of papers citing papers by Kai Kappert
This network shows the impact of papers produced by Kai Kappert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Kappert. The network helps show where Kai Kappert may publish in the future.
Co-authors
The 25 scholars most cited alongside Kai Kappert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment Hit paper breakdown → | 2020 | 802 |
| 2 | 2004 | 113 | |
| 3 | 2008 | 96 | |
| 4 | 2012 | 91 | |
| 5 | 2004 | 82 | |
| 6 | 2007 | 82 | |
| 7 | 2020 | 79 | |
| 8 | 2011 | 78 | |
| 9 | 2010 | 75 | |
| 10 | 2013 | 73 | |
| 11 | 2006 | 69 | |
| 12 | 2004 | 67 | |
| 13 | 2009 | 60 | |
| 14 | 2007 | 58 | |
| 15 | 2007 | 53 | |
| 16 | 2020 | 50 | |
| 17 | 2010 | 50 | |
| 18 | 2001 | 47 | |
| 19 | 2011 | 44 | |
| 20 | 2017 | 43 |
About Kai Kappert
Kai Kappert is a scholar working on Molecular Biology, Immunology, Cancer Research, Epidemiology and Oncology, having authored 100 papers that have together received 3.2k indexed citations. Recurring topics across this work include Protein Tyrosine Phosphatases (17 papers), Galectins and Cancer Biology (8 papers), Cell Adhesion Molecules Research (7 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (7 papers), Peroxisome Proliferator-Activated Receptors (5 papers), Angiogenesis and VEGF in Cancer (5 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Protease and Inhibitor Mechanisms (4 papers). The work is most often cited by research in Immunology (737 citations), Infectious Diseases (560 citations), Immunology and Allergy (125 citations), Neurology (273 citations) and Cancer Research (250 citations). Kai Kappert has collaborated with scholars based in Germany, Sweden and United States. Frequent co-authors include Arne Östman, Ulrich Kintscher, R Tauber, Eckart Fleck, Stephan Rosenkranz, Philipp Stawowy, Thomas Unger, Evren Caglayan, Heike Meýborg and Olli Leppänen. Their work appears in journals such as Biochemical and Biophysical Research Communications, Hypertension, Circulation Research, PLoS ONE and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.